Pathogenicity of human oral strains of haemophili: enzymes, anaerobiosis and effects on mice and rabbits.
D000190:Actinomyces / Q000254:growth & development; D000693:Anaerobiosis; D000818:Animals; D002807:Chondroitin; D003016:Clostridium perfringens / Q000254:growth & development; D003017:Clostridium tetani / Q000254:growth & development; D003851:Deoxyribonucleases / Q000032:analysis; D003911:Dextrans; D005337:Fibrin / Q000378:metabolism; D006190:Haemophilus / Q000201:enzymology / Q000378:metabolism / Q000472:pathogenicity*; D006193:Haemophilus influenzae / Q000201:enzymology; D006821:Hyaluronoglucosaminidase / Q000096:biosynthesis; D007274:Injections, Intraperitoneal; D007928:Lethal Dose 50; D008049:Lipase / Q000032:analysis; D051379:Mice; D009055:Mouth / Q000382:microbiology*; D010100:Oxygen; D010740:Phospholipases / Q000032:analysis; D011817:Rabbits; D012790:Shwartzman Phenomenon / Q000209:etiology; D013429:Sulfatases / Q000032:analysis; D014678:Veillonella / Q000254:growth & development
D003911:Dextrans; D005337:Fibrin; D002807:Chondroitin; D003851:Deoxyribonucleases; D010740:Phospholipases; D008049:Lipase; D013429:Sulfatases; D006821:Hyaluronoglucosaminidase; D010100:Oxygen